Home › Funds › Catalio Capital Management, LP › KLRA
Catalio Capital Management, LP position in KLRA
KAILERA THERAPEUTICS INC · Health Care
Catalio Capital Management, LP reported holding 468,750 shares of KLRA (KAILERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$10.3M, representing 1.94% of its reported portfolio and ranking #21 among its reported holdings. Catalio Capital Management, LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's KLRA position evolved
Catalio Capital Management, LP first disclosed a stake in KLRA in Q2 2026 at 468,750 shares (US$10.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 468.75K | $10.33M | New |
About KLRA and 13F data
KLRA (KAILERA THERAPEUTICS INC) is a Health Care company. 110 other funds we track also report a position in KLRA — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$578.4M), Bain Capital Life Sciences Investors, LLC (US$497.5M), RTW INVESTMENTS, LP (US$237.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KLRA
- BAIN CAPITAL INVESTORS LLC 26.26M sh · $578.41M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 22.58M sh · $497.51M · Q2 2026
- RTW INVESTMENTS, LP 10.78M sh · $237.41M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 5.17M sh · $113.92M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.46M sh · $54.09M · Q2 2026
- Siren, L.L.C. 2.21M sh · $48.78M · Q2 2026
- Farallon Capital Management 1.10M sh · $24.23M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 1.10M sh · $24.23M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.10M sh · $24.23M · Q2 2026
- Trails Edge Capital Partners, LP 984.79K sh · $21.69M · Q2 2026
- Cormorant Asset Management, LP 550.00K sh · $12.12M · Q2 2026
- a16z Capital Management, L.L.C. 140.00K sh · $3.08M · Q2 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held KLRA?
Catalio Capital Management, LP has disclosed KLRA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Catalio Capital Management, LP's current position in KLRA?
As of Q2 2026, Catalio Capital Management, LP holds 468.75K shares of KLRA (KAILERA THERAPEUTICS INC), valued at $10.33M, representing 1.94% of its reported portfolio and ranking #21.
Has Catalio Capital Management, LP been buying or selling KLRA?
In the latest 13F filing (Q2 2026), Catalio Capital Management, LP newly opened its position in KLRA.
Which other funds hold KLRA?
Other major institutional holders of KLRA include BAIN CAPITAL INVESTORS LLC, Bain Capital Life Sciences Investors, LLC, RTW INVESTMENTS, LP, among 110 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.